EPISODE · May 6, 2026 · 30 MIN
This Fortnight in Medicine XXV
from Sensible Medicine · host Adam Cifu, MD, John Mandrola, and Andrew J Foy
Oral Nirmatrelvir–Ritonavir for Covid-19 in Higher-Risk Outpatients* Real-World Effectiveness of Nirmatrelvir–Ritonavir Against Severe Outcomes of COVID-19 in Taiwan: A Nationwide Population-Based Cohort StudyThree Low-Dose Antihypertensive Agents in a Single Pill after Intracerebral Hemorrhage* Effect of Combination Therapy on Adherence Among US Patients Initiating Therapy for Hypertension: a Cohort Study This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.sensible-med.com/subscribe
Embed this episode
NOW PLAYING
This Fortnight in Medicine XXV
No transcript for this episode yet
Similar Episodes
No similar episodes found.